Description |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Getz Pharma |
Trastuzumab 440mg/10ml |
Product Type |
Product Size |
Tablets |
30'S |
Product Company |
Beacon Pharmaceuticals |
Sorafenib 200mg |
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Manufacture Deva Holding / Marketed by Searle |
Letrozole 2.5mg |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Roche Pharma |
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Searle Pharma |
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Bevacizumab 400mg/16ml |
Content | Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. | Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer that has come back or spread to other parts of your body. Sorafenib is an antineoplastic (cancer) agent.
| Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon. | "
Rituximab is a biological therapy used for rheumatoid arthritis, lupus, vasculitis and dermatomyositis | Rituximab, an anti CD20 monoclonal antibody, is used in the management of lymphoproliferative and autoimmune conditions. | "
Bevacizumab is a type of targeted cancer drug treatment. It is also known as Avastin. It is a treatment for a number of different cancer types. |
Reviews
There are no reviews yet.